Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials

Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials

AimsAntithrombotic secondary prevention in stable cardiovascular disease (SCVD) patients at high ischemic risk remains unclear. We compared the efficacy and safety of aspirin monotherapy, clopidogrel monotherapy, ticagrelor monotherapy, rivaroxaban monotherapy, clopidogrel plus aspirin, ticagrelor p...

Full description

Bibliographic Details
Main Authors: Houyong Zhu, Xiaoqun Xu, Hanxin Wang, Qilan Chen, Xiaojiang Fang, Jianwu Zheng, Beibei Gao, Guoxin Tong, Liang Zhou, Tielong Chen, Jinyu Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
stable cardiovascular disease
coronary artery disease
peripheral artery disease
secondary prevention
antithrombotic therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1040473/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1040473/full

Similar Items